Citation Impact
Citing Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Cancer statistics, 2022
2022 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Symptoms and problems with functioning among women and men with inoperable lung cancer—A longitudinal study
2007
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
2014
Tumor angiogenesis: causes, consequences, challenges and opportunities
2019
Cancer Statistics, 2021
2021 Standout
Improving the Lung Cancer Resection Rate in the US Department of Veterans Affairs Health System
2006
BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma
2013
Surgical Resection in Combination With Lung Volume Reduction Surgery for Stage I Non-Small Cell Lung Cancer
2010
Establishing the Diagnosis of Lung Cancer
2013 Standout
Assessment of tumor response in malignant pleural mesothelioma
2007
Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients
2008
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
2013
Improving Survival and Reducing Toxicity with Chemotherapy in Advanced Non-Small Cell Lung Cancer
2005
Role of Diffusing Capacity in Predicting Complications after Lung Resection for Cancer
2007
Lung cancer: clinical presentation and specialist referral time
2004
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
Guidelines on the radical management of patients with lung cancer
2010
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Relationship of shuttle walk test and lung cancer surgical outcome
2004
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium
2010
Measured FEV1 in the first postoperative day, and not ppoFEV1, is the best predictor of cardio-respiratory morbidity after lung resection☆
2006
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238
2007
Marine natural products
1990 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Cancer drug resistance: an evolving paradigm
2013 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Oxygen desaturation during maximal stair-climbing test and postoperative complications after major lung resections☆
2007
Exercise Standards for Testing and Training
2013 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Reliability of Quantitative Computed Tomography to Predict Postoperative Lung Function in Patients With Chronic Obstructive Pulmonary Disease Having a Lobectomy
2005
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Performance at Symptom-Limited Stair-Climbing Test is Associated With Increased Cardiopulmonary Complications, Mortality, and Costs After Major Lung Resection
2008
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
New drugs in the treatment of non-small cell lung cancer
1995
Predictors of an Appropriate Admission to an ICU after a Major Pulmonary Resection
2005
Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy
2006
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
2002
Lung cancer: current therapies and new targeted treatments
2016 Standout
The Effects of Different Silicas on Arachidonic Acid Metabolism in Alveolar Macrophages
1990
Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
1991
A model to predict the immediate postoperative FEV1 following major lung resections
2007
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
2012
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent
2011
Is Cardiopulmonary Exercise Testing a Useful Test Before Esophagectomy?
2007
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
2013
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery
2007
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Chemotherapy for Malignant Pleural Mesothelioma
2003
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Diffusing Capacity Predicts Morbidity After Lung Resection in Patients Without Obstructive Lung Disease
2008
Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non-Small-Cell Lung Cancer
2005
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Trends in Hospital Volume and Operative Mortality for High-Risk Surgery
2011 Standout
New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the seventh world conference on lung cancer
1995
Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study
2005
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
2008
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy
2004
Operative Mortality and Respiratory Complications After Lung Resection for Cancer: Impact of Chronic Obstructive Pulmonary Disease and Time Trends
2006
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review
2011
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial
2000
Pulmonary Toxicity of Chemotherapy
2006
PEGylation, successful approach to drug delivery
2005 Standout
PATHOLOGIC ANALYSIS OF PHOTOTHERMAL AND PHOTOMECHANICAL EFFECTS OF LASER–TISSUE INTERACTIONS
1991
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
2004
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Exercise limitation in chronic heart failure: Central role of the periphery
1996
A big step in the study of small cell lung cancer
2003
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Use of Quantitative Lung Scintigraphy to Predict Postoperative Pulmonary Function in Lung Cancer Patients Undergoing Lobectomy
2004
Cardiopulmonary exercise testing as a risk assessment method in non cardio‐pulmonary surgery: a systematic review
2009
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
2002
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
2009
Advances in Malignant Mesothelioma
2005 Standout
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
2003
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
2013
Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection
2006
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
1998 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer
1990
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
2014
Chemotherapy for advanced gastric cancer
2017 Standout
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives
2015
Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer
2005
Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled Trials
2004
Aluminum Lactate Treatment Alters the Lung Biological Activity of Quartz
1986
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Prediction of Postoperative Lung Function in Patients with Lung Cancer
2002
Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma.
1982
Size Dependent Lymphatic Short Term Clearance of Amosite Fibres in the Lung
1988
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
2017
Determination of the absolute configuration and evaluation of the in vitro antitumor activity of dilospirane B
2012
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
2004
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Effect of Symptom-To-Treatment Interval on Prognosis in Lung Cancer
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Ventilation-Perfusion Scintigraphy to Predict Postoperative Pulmonary Function in Lung Cancer Patients Undergoing Pneumonectomy
2006
Cardiopulmonary Exercise Testing in the Clinical Evaluation of Patients With Heart and Lung Disease
2011
Mast cells and inhalation of asbestos in rats.
1984
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods
2007
Mechanisms of Pulsed Laser Ablation of Biological Tissues
2003 Standout
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
2014
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
Cardiopulmonary Exercise Tests and Lung Cancer Surgical Outcome
2005
The Future of Aerobic Exercise Testing in Clinical Practice: is It the Ultimate Vital sign?
2010
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Works of Robin Rudd being referenced
Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948)
1983
The Physiologic Evaluation of Patients With Lung Cancer Being Considered for Resectional Surgery*
2003
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
2012
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development
2004
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer
1992
Reduced pulmonary microvascular permeability in severe chronic left heart failure
1992
Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
2009
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
2008
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer
1990
Initial Evaluation of the Patient With Lung Cancer*
2003
Fibreoptic bronchoscopy: Effect of experience of operator on diagnostic yield of bronchial biopsy in bronchial carcinoma
1982
O-179 The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting
2003
Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer
2009
In vitro effects of mineral dusts
1987
Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma
2000
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
2012
Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials
2004
Pulmonary toxicity and cancer treatment
2004
Surgical applications of lasers
1988
In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion
2006
Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis
2006
O-212 The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the radical radiotherapy setting
2003
O-60 The big lung trial quality of life study: Determining the effect of cisplatin-based chemotherapy for supportive care patients with non-small cell lung cancer (NSCLC)
2003